🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the efficacy and safety of the combi...
Status
Completed
Location
University of South Alabama, Mitchell Cancer Institute ( Site 0065)
Start Date
2019-05-02
Trial ID
NCT03834506
Treatments Being Tested
The purpose of the Phase 1 part of the study is to determine the maximum to...
Status
Terminated
Location
California Cancer Associates For Research and Exellence, cCare
Start Date
2014-07-30
Trial ID
NCT01999335
Treatments Being Tested
This study has 2 parts: a Dose Escalation Part and a Dose Expansion Part. ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-10
Trial ID
NCT03283046
Treatments Being Tested
The goal of this clinical trial is to learn if medroxyprogesterone acetate ...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Xinxiang Medical University
Start Date
2025-08-10
Trial ID
NCT07124195
The primary purpose of this study is to determine the overall response rate...
Status
Withdrawn
Location
CEHON Centro de Hematologia e Oncologia da Bahia
Start Date
2019-09-30
Trial ID
NCT03608501
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of siltuxi...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00402181
Treatments Being Tested
This phase II trial study assessing the activity of metformin when given to...
Status
Terminated
Location
UOPECCAN - Hospital do Câncer de Cascavel
Start Date
2017-01
Trial ID
NCT02967276
Treatments Being Tested
The main purpose of this study is to determine the recommended doses of sel...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2014-09-23
Trial ID
NCT02186834
Treatments Being Tested
This study will compare how safe and effective sacituzumab tirumotecan is v...
Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center ( Site 0119)
Start Date
2024-05-03
Trial ID
NCT06356311
An unrandomized phase 2 study of selinexor in combination with lenalidomide...
Status
Active Not Recruiting
Location
Aalborg University Hospital
Start Date
2021-08-18
Trial ID
NCT04717700
Treatments Being Tested